1. Polymorphisms of the IL-23R gene are associated with primary immune thrombocytopenia but not with the clinical outcome of pulsed high-dose dexamethasone therapy.
- Author
-
Zhan Y, Hua F, Ji L, Wang W, Zou S, Wang X, Li F, and Cheng Y
- Subjects
- Adolescent, Adult, Aged, China epidemiology, Dexamethasone administration & dosage, Dose-Response Relationship, Drug, Ethnicity genetics, Female, Gene Frequency, Genes, Recessive, Genetic Predisposition to Disease, Genotype, Humans, Male, Middle Aged, Purpura, Thrombocytopenic, Idiopathic drug therapy, Purpura, Thrombocytopenic, Idiopathic epidemiology, Purpura, Thrombocytopenic, Idiopathic ethnology, Receptors, Interleukin physiology, Treatment Outcome, Young Adult, Dexamethasone therapeutic use, Polymorphism, Single Nucleotide, Purpura, Thrombocytopenic, Idiopathic genetics, Receptors, Interleukin genetics
- Abstract
Primary immune thrombocytopenia (ITP) is an autoimmune heterogeneous disorder that is characterized by decreased platelet count. The interleukin-23 receptor (IL-23R) has been identified as a susceptibility gene for the development of multiple autoimmune diseases. To investigate the possible association of IL-23R gene single-nucleotide polymorphisms (SNPs) with ITP and the association with the clinical outcome of pulsed high-dose dexamethasone (HD-DXM) therapy, four SNPs in the IL-23R gene, rs10889677, rs1884444, rs7517847, and rs11209032, were tested in a cohort of 75 ITP subjects and 81 controls by direct sequencing. IL-23R rs1884444 GT/TT variant genotypes were observed to be associated with significantly increased risk of ITP as compared with controls (GT/TT vs. GG: odds ratio (OR) 2.776, 95 % confidence intervals (CI) 1.086-7.090, p = 0.028). However, other three SNPs revealed no statistically significant differences between patients and controls (rs10889677 CA/AA vs. CC: OR 2.200, 95 % CI 0.727-6.661, p = 0.155; rs11209032 GA/AA vs. GG: OR 0.747, 95 % CI 0.379-1.472, p = 0.399; rs7517847 TG/GG vs. TT: OR 1.031, 95 % CI 0.544-1.956, p = 0.925). Furthermore, IL-23R SNPs revealed no association with clinical outcome of HD-DXM therapy. This study suggests that polymorphism in the IL-23R gene, rs1884444, indicates a significant association with susceptibility to ITP in a recessive genetic model but does not have association with the clinical outcome of HD-DXM therapy.
- Published
- 2013
- Full Text
- View/download PDF